FDA warns against compounding semaglutide

Time : 2nd of June 2023 04:00:38 PM

The agency received reports of adverse events after some patients used compounded semaglutide. Thus, FDA warned against using compounded drugs when an approved drug is available. Patients and physicians are urged to understand that such products may contain salt forms and FDA does not review the safety and effectiveness of compounded versions of drugs.



FDA, semaglutide, warning, compounded

Recent Posts

An AI-assisted colonoscopy gets FDA approval
3rd of August 2023 02:43:05 PM

Severe sleep apnea tied to brain abnormalities
1st of August 2023 12:22:47 PM

FDA approves another OTC naloxone nasal spray
1st of August 2023 11:46:02 AM